RESEARCH
PUBLICATIONS
GNB1 Publications
2026
-
Myoclonus-dystonia due to novel mutation in the guanine nucleotide-binding protein (GNB1) gene
Street D, Teare L, Georgieva T, et al. Myoclonus-dystonia due to novel mutation in the guanine nucleotide-binding protein (GNB1) gene. Parkinsonism Relat Disord. 2026;147:107822. doi:10.1016/j.parkreldis.2025.107822
https://pubmed.ncbi.nlm.nih.gov/40210557/
-
Expert comment for "Myoclonus-dystonia due to novel mutation in the guanine nucleotide-binding protein (GNB1) gene"
de Carvalho Aguiar P. Expert comment for "Myoclonus-dystonia due to novel mutation in the guanine nucleotide-binding protein (GNB1) gene". Parkinsonism Relat Disord. 2026;147:108338. doi:10.1016/j.parkreldis.2026.108338
https://pubmed.ncbi.nlm.nih.gov/42067479/#full-view-affiliation-1
-
GIRK Channel Loss of Function Increases Dendritic Excitability in a Mouse Model of GNB1 Encephalopathy
Gritz S, Voleti A, Scarnati MS, Galloni AR, Milstein AD. Girk channel loss of function increases dendritic excitability in a mouse model of GNB1 encephalopathy. bioRxiv. 2026; doi:10.64898/2026.08.08.743706. https://www.biorxiv.org/content/10.64898/2026.08.08.743706v1.full
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
G-protein Publications
2025
-
Loss of expression and function of Gβγ by GNB1 encephalopathy-associated L95P mutation of the Gβ1 subunit
Reddy HP, Keren-Raifman T, Tabak G, Dascal N, Yakubovich D. Loss of expression and function of Gβγ by GNB1 encephalopathy-associated L95P mutation of the Gβ1 subunit. Front Pharmacol. 2025;16:1592012. doi:10.3389/fphar.2025.1592012
-
Integrative proteomic and lipidomic analysis of GNB1 and SCARB2 knockdown in human subcutaneous adipocytes
Kitamoto T, Kitamoto A. Integrative proteomic and lipidomic analysis of GNB1 and SCARB2 knockdown in human subcutaneous adipocytes. Loor JJ, ed. PLOS ONE. 2025;20(3):e0319163. doi:https://doi.org/10.1371/journal.pone.0319163
2023
2022
2021
2006
Therapies and Drug-related
2025
-
Hit identification for membrane protein drug discovery
Rawlins P. Hit identification for membrane protein drug discovery. Drug Target Review. 2025.